Hot Pursuit     30-May-24
Alembic Pharma gets US FDA nod for heart failure-treatment drug
Alembic Pharmaceuticals said that has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Sacubitril and Valsartan Tablets.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Entresto Tablets of Novartis Pharmaceuticals Corporation (Novartis).

Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. It is also indicated for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in paediatric patients aged one year and older.

Sacubitril and Valsartan Tablets have an estimated market size of US$ 5.3 billion for twelve months ending March 2024 according to IQVIA.

Alembic has a cumulative total of 202 ANDA approvals (174 final approvals and 28 tentative approvals) from US FDA.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. The company manufactures and markets generic pharmaceutical products all over the world.

The company’s consolidated net profit increased jumped 48.01% to Rs 180.45 crore despite of 8.05% fall in revenue from operations to Rs 1,630.57 crore in Q3 FY24 over Q3 FY23.

The scrip rose 0.10% to currently trade at Rs 947.10 on the BSE.

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
 ( Results - Announcements 09-May-24   15:06 )
  Alembic Pharma gains after USFDA tentative nod for Acalabrutinib capsules
 ( Hot Pursuit - 19-Jan-23   14:12 )
  Alembic Pharma gets PAS nod from USFDA for pregabalin capsules
 ( Hot Pursuit - 22-Dec-22   14:57 )
  Alembic Pharmaceuticals to discuss results
 ( Corporate News - 17-Oct-23   10:13 )
  Alembic Pharmaceuticals Ltd down for fifth straight session
 ( Hot Pursuit - 19-Sep-22   13:35 )
  Alembic Pharmaceuticals receives USFDA's tentative approval for Acalabrutinib Capsules
 ( Corporate News - 19-Jan-23   14:19 )
  Alembic Pharmaceuticals receives EIR for its oncology unit at Panelav
 ( Corporate News - 06-May-24   08:52 )
  Alembic Pharma get US FDA nod for acne topical gel
 ( Hot Pursuit - 08-Aug-22   11:19 )
  Alembic Pharmaceuticals receives USFDA approval for Glycopyrrolate Injection
 ( Corporate News - 01-Nov-22   11:41 )
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 09-May-24   14:56 )
  Alembic Pharma rises after USFDA approval for antifungal drug
 ( Hot Pursuit - 08-Apr-21   11:56 )
Other Stories
  Inox Green Energy board OKs fund raising proposal
  22-Jun-24   17:00
  Cipla Goa facility gets 6 USFDA observations
  22-Jun-24   16:22
  EIH CFO Kallol Kundu resigns
  22-Jun-24   14:20
  Sky Gold acquires entire stake in Starmangalsutra & Sparkling Chains
  22-Jun-24   13:31
  TVS Motor inks pact with CSC Grameen eStores for its CV range
  22-Jun-24   12:27
  Prestige Estates to raise Rs 5000 crore via QIP
  22-Jun-24   11:59
  JSW Energy arm bags LoA from SECI
  22-Jun-24   10:56
  RVNL emerges as L-1 bidder for Rs 191-cr railway project
  22-Jun-24   09:54
  Bajaj Consumer hits 52-week high as board OKs Rs 166-cr share buyback
  21-Jun-24   15:28
  GRM Overseas rallies as board OKs Rs 136-cr preferential issue
  21-Jun-24   15:19
Back Top